ArticleWorld journal of microbiology & biotechnology2025
Green synthesis of gamma rays-induced melanin-based bismuth oxide nanoparticles for evaluation of the antibacterial and anti-virulence activities against extra-intestinal pathogenic bacteria.
Article in World journal of microbiology & biotechnology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- Remedial applications of biosynthesized metal oxide nanoparticles against pathogenic microorganisms.Discover nano · 2026Review
- Facile green synthesis of selenium nanoparticles using olive (Olea europaea) leaf extract and their antimicrobial and antibiofilm properties.Scientific reports · 2026Article
- Diagnostic performance of rapid screening tests for asymptomatic bacteriuria among pregnant women in a tertiary care hospital in India.Scientific reports · 2026Article
- Antimicrobial and anti-virulent efficacies of melanin, and risk factors associated withFrontiers in cellular and infection microbiology · 2026Article
- Silica Spheres Functionalized with Silver and Bismuth Nanoparticles-Antibacterial Activity Against Clinically Relevant Bacterial Pathogens.International journal of molecular sciences · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The rise of microorganisms that are resistant to drugs is one of the significant challenges facing the health sector. The need to identify effective alternatives facing bacterial diseases is significantly highlighted. Nanomaterials have the potential to be a game-changing weapon in the battle against infectious diseases. Melanin, with the assistance of different doses of gamma rays, successfully produced highly stable Bi2O3 NPs. The most effective dose was 40 kGy. Bi2O3 NPs were characterized using FTIR, XRD, DLS/zeta potential, and TEM. In this study, the antibacterial efficacy of Bi2O3 NPs versus the extra-intestinal bacteria Citrobacter freundii and Enterobacter aerogenes was evaluated. Bi2O3 NPs at 200 µL generate inhibition zone diameters of 35.26 ± 0.305 and 38.42 ± 0.570 mm for C. freundii and E. aerogenes, respectively. Bi2O3 NPs at 200 µL caused significant biofilm reduction of 81.05 and 88.25% also, registered a significant decline in the colony count of (0.29 × 108) for C. freundii and (0.15 × 108) for E. aerogenes. The Bi2O3 NPs greatly decreased catalase activity, displaying 1.5 ± 0.62 and 6.0 ± 0.91 U/mL, and lipase activity exhibiting 12.13 ± 0.34 and 6.7 ± 0.26 U/mL for C. freundii and E. aerogenes, respectively. SEM observations indicated that the bacterial cell membrane was disrupted, resulting in significant ultrastructure alterations. Bi2O3 NPs reported a moderate cytotoxic effect on normal kidney epithelial cells with IC50 value of 513.9 ± 2.71 µg/mL. In conclusion, Bi2O3 NPs exhibited potential antibacterial activity, suggesting recommended usage in medical fields. The novelty of this study is the use of low-dose gamma irradiation to synthesize highly stable Bi2O3 NPs.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.